NEW CLINICAL EVIDENCE: 17x Greater Therapeutic Dose-Response for Concussion Treatment
Robotic-Assisted Multimodal Neurorehab produces 17× greater therapeutic dose-response and more complete concussion recovery than standard of care alone.
Persistent Post-Concussion Syndrome (PPCS) remains one of the most challenging conditions to treat using traditional neurorehabilitation methods. Standard therapies often fail to fully resolve vestibular, sensorimotor, and cognitive deficits—leading to prolonged recovery, functional limitations, and reduced quality of life. · 2× greater improvement in balance and postural control · 8× greater reduction in symptom severity · 17× higher therapeutic dose-response per session By integrating computer-controlled, precisely dosed, high-intensity motion stimulation with interactive visuomotor, visual-vestibular, and cognitive tasks, GyroStim significantly enhances treatment efficiency and accelerates recovery trajectories. Clinicians report greater patient engagement, faster discharge rates, and superior long-term outcomes—redefining what’s possible in neurorehabilitation. |